Increasing intakes of the long-chain ω-3 docosahexaenoic acid: Effects on platelet functions and redox status in healthy men

FASEB Journal

Volumn 23, Issue 9, 2009, Pages 2909-2916

  Guillot, Nicolas ^a,b,c,d   Caillet, Emilie ^a,b,c,d   Laville, Martine ^a,b,c,d,e   Calzada, Catherine ^a,b,c,d   Lagarde, Michel ^a,b,c,d   Véricel, Evelyne ^a,b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b Univ Lyon   (France)

^c UNIVERSITÉ DE LYON   (France)

^d CEMAGREF   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Arachidonic acid; Isoprostane; Oxidative stress; Vitamin E

Indexed keywords

8 ISOPROSTANE; ALPHA TOCOPHEROL; CERVONIC ACID; CHOLESTEROL ESTER; FATTY ACID ESTER; ISOPROSTANE; LIPOXYGENASE; LONG CHAIN FATTY ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPID; PRO MIND; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE METABOLISM; TREATMENT DURATION; URINALYSIS;

AGED; ANTIOXIDANTS; BLOOD PLATELETS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; HUMANS; ISOPROSTANES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPIDS; PLATELET ACTIVATION; VITAMIN E;

EID: 70349304408     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-133421     Document Type: Article

References (47)

1. Kromhout, D., Bosschieter, E. B., and de Lezenne Coulander, C. (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 312, 1205-1209
2. GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione-Investigators. (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447-455
3. Kris-Etherton, P. M., Harris, W. S., and Appel, L. J. (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757 (Pubitemid 35364932)
4. Hirafuji, M., Machida, T., Hamaue, N., and Minami, M. (2003) Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J. Pharmacol. Sci. 92, 308-316 (Pubitemid 37086713)
5. Sacks, F. M., Stone, P. H., Gibson, C. M., Silverman, D. I., Rosner, B., and Pasternak, R. C. (HARP Research Group) (1995) Controlled trial of fish oil for regression of human coronary atherosclerosis. J. Am. Coll. Cardiol. 25, 1492-1498
6. Hooper, L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Ness, A. R., Capps, N. E., Davey Smith, G., Riemersma, R. A., and Ebrahim, S. (2004) Omega 3 fatty acids for prevention and treatment of cardiovascular disease. [Online] Cochrane Database Syst. Rev. 4, CD003177 doi: 10.1002/14651858.CD003177.pub2
7. Wagner, B. A., Buettner, G. R., and Burns, C. P. (1994) Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry 33, 4449-4453
8. Yagi, K. (1987) Lipid peroxides and human diseases. Chem. Phys. Lipids 45, 337-351
9. Meydani, M., Natiello, F., Goldin, B., Free, N., Woods, M., Schaefer, E., Blumberg, J. B., and Gorbach, S. L. (1991) Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J. Nutr. 121, 484-491
10. Allard, J. P., Kurian, R., Aghdassi, E., Muggli, R., and Royall, D. (1997) Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids 32, 535-541 (Pubitemid 27213324)
11. Higdon, J. V., Liu, J., Du, S. H., Morrow, J. D., Ames, B. N., and Wander, R. C. (2000) Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes. Am. J. Clin. Nutr. 72, 714-722 (Pubitemid 30667092)
12. Higdon, J. V., Du, S. H., Lee, Y. S., Wu, T., and Wander, R. C. (2001) Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J. Lipid Res. 42, 407-418 (Pubitemid 32270065)
13. Mori, T. A., Woodman, R. J., Burke, V., Puddey, I. B., Croft, K. D., and Beilin, L. J. (2003) Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med. 35, 772-781 (Pubitemid 37329480)
14. Wright, S. A., O'Prey, F. M., McHenry, M. T., Leahey, W. J., Devine, A. B., Duffy, E. M., Johnston, D. G., Finch, M. B., Bell, A. L., and McVeigh, G. E. (2008) A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 67, 841-848
15. Richard, D., Kefi, K., Barbe, U., Bausero, P., and Visioli, F. (2008) Polyunsaturated fatty acids as antioxidants. Pharmacol. Res. 57, 451-455
16. Véricel, E., Januel, C., Carreras, M., Moulin, P., and Lagarde, M. (2004) Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 53, 1046-1051 (Pubitemid 38436617)
17. Massberg, S., Brand, K., Gruner, S., Page, S., Muller, E., Muller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., Nieswandt, B., and Gawaz, M. (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196, 887-896
18. Dyerberg, J., and Bang, H. O. (1979) Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2, 433-435 (Pubitemid 9250399)
19. von Schacky, C., and Weber, P. C. (1985) Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest. 76, 2446-2450
20. Demaison, L., and Moreau, D. (2002) Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell. Mol. Life Sci. 59, 463-477 (Pubitemid 34267387)
21. Croset, M., Véricel, E., Rigaud, M., Hanss, M., Courpron, P., Dechavanne, M., and Lagarde, M. (1990) Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid. Thromb. Res. 57, 1-12 (Pubitemid 20023895)
22. Véricel, E., Calzada, C., Chapuy, P., and Lagarde, M. (1999) The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 147, 187-192 (Pubitemid 29486788)
23. Véricel, E., Polette, A., Bacot, S., Calzada, C., and Lagarde, M. (2003) Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets. J. Thromb. Haemostasis 1, 566-572
24. Kramer, R. M., Roberts, E. F., Manetta, J. V., Hyslop, P. A., and Jakubowski, J. A. (1993) Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets. J. Biol. Chem. 268, 26796-26804 (Pubitemid 23361770)
25. Bryant, R. W., and Bailey, J. M. (1980) Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats. Biochem. Biophys. Res. Commun. 92, 268-276
26. Hamberg, M., Svensson, J., and Samuelsson, B. (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U. S. A. 72, 2994-2998
27. Lagarde, M., Bryon, P. A., Guichardant, M., and Dechavanne, M. (1980) A simple and efficient method for platelet isolation from their plasma. Thromb. Res. 17, 581-588 (Pubitemid 10129052)
28. Boukhchache, D., and Lagarde, M. (1982) Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim. Biophys. Acta 713, 386-392 (Pubitemid 13222955)
29. Bowyer, D. E., Leat, W. M., Howard, A. N., and Gresham, G. A. (1963) The determination of the fatty acid composition of serum lipids separated by thin-layer chromatography; and a comparison with column chromatography. Biochim. Biophys. Acta. 70, 423-431
30. Brossard, N., Croset, M., Pachiaudi, C., Riou, J. P., Tayot, J. L., and Lagarde, M. (1996) Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am. J. Clin. Nutr. 64, 577-586 (Pubitemid 26334237)
31. Born, G. V. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-929
32. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
33. Coulon, L., Calzada, C., Moulin, P., Véricel, E., and Lagarde, M. (2003) Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. Free Radic. Biol. Med. 35, 616-625 (Pubitemid 37101129)
34. Morris, M. C., Sacks, F., and Rosner, B. (1993) Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523-533 (Pubitemid 23228051)
35. Kelley, D. S., Siegel, D., Vemuri, M., and Mackey, B. E. (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am. J. Clin. Nutr. 86, 324-333 (Pubitemid 47256914)
36. Hamazaki, T., Sawazaki, S., Asaoka, E., Itomura, M., Mizushima, Y., Yazawa, K., Kuwamori, T., and Kobayashi, M. (1996) Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults. J. Nutr. 126, 2784-2789 (Pubitemid 26376615)
37. Milte, C. M., Coates, A. M., Buckley, J. D., Hill, A. M., and Howe, P. R. (2008) Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br. J. Nutr. 99, 1083-1088
38. Conquer, J. A., and Holub, B. J. (1996) Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J. Nutr. 126, 3032-3039
39. Conquer, J. A., and Holub, B. J. (1996) Dietary fatty acids in human thrombosis and hemostasis. Lipids 32, 341-345
40. Knapp, H. R. (1997) Dietary fatty acids in human thrombosis and hemostasis. Am. J. Clin. Nutr. 65, 1687S-1698S
41. Breslow, J. L. (2006) n-3 fatty acids and cardiovascular disease. Am J. Clin. Nutr. 83, 1477S-1482S
42. Larson, M. K., Ashmore, J. H., Harris, K. A., Vogelaar, J. L., Pottala, J. V., Sprehe, M., and Harris, W. S. (2008) Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb. Haemostasis 100, 634-641
43. Corey, E. J., Shih, C., and Cashman, J. R. (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 80, 3581-3584
44. Gresele, P., Pignatelli, P., Guglielmini, G., Carnevale, R., Mezzasoma, A. M., Ghiselli, A., Momi, S., and Violi, F. (2008) Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J. Nutr. 138, 1602-1608
45. Morrow, J. D. (2000) The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab. Rev. 32, 377-385
46. Yavin, E. (2006) Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression. Prostaglandins Leukot. Essent. Fatty Acids 75, 203-211
47. International Society for the Study of Fatty Acids and Lipids. (2004) Recommendations for intake of polyunsaturated fatty acids in healthy adults. Retrieved May 1, 2009, from http://www.issfal.org.uk/lipid-matters/issfal- policy-statements/statement-3-pufa-in-adults-10.html